Leah Hinson

Leah Hinson serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate the development of medical countermeasures, diagnostics, and laboratory infrastructure for emerging infectious and immunologic threats. She manages a portfolio of complex acquisitions centered on high-containment research capabilities, biosafety equipment, and specialized analytical instrumentation. Her work directly enables NIAID’s operational readiness by securing critical scientific and technical services that underpin public health preparedness and response efforts. Hinson maintains sustained relationships with core contractors including Quality Biological, Inc., a leading provider of biological reference materials and research reagents, and GENOMIC LABS LTD, which supports advanced genomic analysis and diagnostic development. Her contracting approach emphasizes technical precision and regulatory compliance, often engaging vendors with specialized expertise in biosafety Level 3 and 4 environments, GMP-compliant manufacturing, and validated laboratory systems. These partnerships reflect a preference for established, technically qualified suppliers capable of meeting stringent federal bioscience standards. Her procurement activity is overwhelmingly classified as non-set-aside, with 97.7% of awards issued under full and open competition, indicating a primary focus on technical capability over socioeconomic preferences. Only 2.3% of awards are structured as total small business set-asides, suggesting that while small business participation is recognized, it is secondary to mission-critical performance requirements. Hinson’s contracting focus is heavily concentrated in NAICS 811210 (electronic and precision equipment repair and maintenance) and 334516 (analytical laboratory instrument manufacturing), reflecting demand for high-performance instrumentation such as PCR systems, flow cytometers, and biosafety cabinets. She also frequently procures biological product manufacturing (325414) and testing laboratory services (541380), underscoring her expertise in supporting end-to-end research workflows—from reagent production to validated diagnostic testing—within high-containment biomedical environments.